Safety and tolerability of nintedanib in patients with IPF: interim analysis from an open-label extension of the INPULSIS® trials (INPULSIS®-ON) - Crestani, B; Ogura, T; Pelling, K; Quaresma, M; Coeck, C; Kaye, M (Am J Respir Crit Care Med, 2015)